Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
2.48
Ask:
2.52
Spread: 0.04 (1.613%)
Market Cap: £13.56m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Binding Heads of Terms for £19m Capital Raise

20 Feb 2025 07:52

RNS Number : 8518X
Valereum PLC
20 February 2025
 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

20/02/25

 

Valereum Plc

("VLRM" or the "Company")

 

Valereum Plc enters into Binding Heads Of Terms for a Capital Raise of £19 Million with DMC Markets Inc. (Via Valereum Inc., an Entity Formed for the Purpose of the Investment),

Four Strategic Investments and

A Further £1 Million Investment from a UK Institutional Investor

 

Valereum Plc (AQSE: VLRM) is pleased to announce that it has entered into a binding Heads of Terms ("HoT") for a £19 million capital investment ("Investment") from Valereum Inc., an entity formed for the purpose of the investment from DMC Markets Inc. ("DMC"), the completion is subject to finalising satisfactory due diligence. In addition to the investment from DMC via Valereum Inc., acquiring 48.86% of Valereum Plc, there will be an additional £1 million investment from a UK institutional investor.

 

The HoT signed by the parties, as being announced today, contain different terms from the announcement made on 16 December 2024. Notably, DMC via Valereum Inc. will now subscribe for a total of shares worth £19 million (breakdown provided below), whereas the previous announcement stated £13 million. This also includes their acquisition of the shares originally intended to be issued to Blue Sky Vision LLC ("Blue Sky") under the option agreement announced by the Company on 16 December 2024 and 02 January 2025, with subsequent updates provided on 14 February 2025, confirming that Blue Sky will not be proceeding.

 

DMC's £19 Million Investment and Terms

Valereum Plc has agreed to issue Valereum Inc. a total of 170,000,000 ordinary shares in the capital of the Company (the "Subscription Shares"), allocated as follows:

 

- 130,000,000 ordinary shares at an issue price of £0.10 per share (as per the announcement made on 16 December 2024)

- 20,000,000 ordinary shares at an issue price of £0.20 per share

- DMC Markets Inc., via its entity, Valereum Inc. will acquire 20,000,000 ordinary shares at an issue price of £0.10 per share, replacing the previously announced shares which were to be issued to Blue Sky Vision LLC, as per the £2 million option exercise announced on 02 January 2025, alongside the further update to the market on 14 February 2025.

The proceeds of the Investment will be used to make four strategic investments, to provide working capital to support the investments and Valereum Plc's growth plans, and to fund and accelerate the rollout of its tokenisation and digital asset services.

 

Strategic Asset Investments

Part of the proceeds of the Investment will fund the acquisition of minority interests in four complementary strategic assets which have been sourced by DMC ("Strategic Investments"). Upon completion of the Strategic Investments, Valereum Plc will have greater presence across Australasia, Europe, North America and South America, as well as accelerating the Group's provision of Web3, Tokenisation, Defi, Asset Securitisation and Blockchain solutions.

 

Institutional Investor £1m Investment and Terms

Valereum Plc also announces the successful capital raise of an additional £1 million from an UK based institutional investor. Under the agreement, Valereum Plc will issue 5,000,000 ordinary shares at an issue price of £0.20 per share. This additional capital injection provides the Company with further working capital to support its growth plans.

 

Admission of Shares

The Subscription Shares to be issued to DMC via Valereum Inc. and the institutional investor are expected to be admitted to trading on AQSE on or around 04 March 2025, subject to completion of the necessary issuance procedures.

To discover more and for the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub. Here you will find company news and additional content to further explain Valereum Plc's strategy and products.

 

For further information, please contact:

 

Valereum Plc

Peter Sekhon, Investor Relation Director

Engage with the company directly

 

Tel: +44 7938 767319 

Investor Hub

Stanford Capital Partners

Bob Pountney/ Patrick Claridge

 

Tel: +44 023 3650 3650

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge / Gabrielle Cordeiro

 

Tel: +44 20 3855 5551

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

Please visit the Company's website at www.vlrm.com or to engage with the Valereum Plc management team directly by asking questions, watching video
summaries and seeing what other shareholders have to say:

Navigate to our Interactive Investor
hub here: Sign Up

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXKZGZZNGGGKZG
Date   Source Headline
6th Jul 20267:00 amRNSQGP Progress Update
3rd Jul 20261:12 pmRNS-RValereum Vox Issue 6 Published
30th Jun 20266:15 pmRNSResults for the year ended 31 December 2025
19th Jun 20261:00 pmRNS-RValereum Vox Issue 5 Published
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.